The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Coronary interventions
Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study
EuroIntervention 2014;10:916-923 published online ahead of print June 2014. DOI: 10.4244/EIJY14M06_10
Alaide Chieffo1, MD; Gill Louise Buchanan1, MB, ChB; Guido Parodi2, MD; Francesco Versaci3, MD; Renato Maria Bianchi4, MD; Renato Valenti2, MD; Salvatore Saccà3, MD; Annalisa Mongiardo4, MD; Simonetta Span3, RN; Angela Migliorini2, MD; Carmen Spaccarotella4, MD; Bernhard Reimers3, MD; David Antoniucci2, MD; Ciro Indolfi4, MD; Angela Ferrari1, PhD; Akiko Maehara5, MD; Gary S. Mintz5, MD; Antonio Colombo1*, MD; on behalf of the APICE OCT Investigators
1. Interventional Cardiology Unit, San Raffaele Scientific Hospital, Milan, Italy; 2. Division of Cardiology, Careggi Hospital, Florence, Italy; 3. Cardiology Department, Mirano Hospital, Mirano, Italy; 4. Division of Cardiology, URT CNR IFC, Magna Graeci
Aims: To our knowledge, no randomised study has compared rates of uncovered stent struts in everolimus (EES) vs. new-generation zotarolimus-eluting (ZES-R) stents in acute coronary syndro